Barriers to treatments that may help prevent cardiovascular disease include issues related to gender, age, inflammation and testing, Dr. Roger Blumenthal told the Cardiometabolic Health Congress. Blumenthal said while evidence shows patients older than 75 who do not have occlusive vascular disease do not appear to gain a statistical benefit from statins, he may still aggressively treat risk factors to try to avoid high-cost procedures.
CVD prevention barriers include gender, age, inflammation, testing
Sign up for SNMMI SmartBrief
Nuclear medicine and molecular imaging news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.